http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108125926-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5169
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
filingDate 2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108125926-B
titleOfInvention Preparation method and application of magnetic nanoparticles spanning blood-eye barrier
abstract The invention discloses a preparation method and application of magnetic nanoparticles spanning blood-eye barriers, which comprises the following steps: taking purified bacterial magnetosomes BMs, and combining amino terminals of the bacterial magnetosomes BMs with sulfydryl of cysteine in TAT polypeptide by using N-succinimide 3- (2-pyridine dithio) propionate as a cross-linking agent to obtain magnetic nanoparticles capable of crossing blood eye barriers, wherein the magnetic nanoparticles are TAT-BMs composite carriers. The magnetic nano-particles can cross the blood-eye barrier, and the application potential of the magnetic nano-material in the treatment of eye diseases is expanded.
priorityDate 2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422154253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425784485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448518658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100682

Total number of triples: 36.